ArticleOncotarget2016

WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.

Chen-Xu Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.